By Sheri Kasprzak
New York, April 18 - The Memorial Sloan-Kettering Cancer Center priced $161.99 million in series 2008A-1 revenue bonds, an official statement said.
The bonds (Aa2/AA/AA) were sold through the Dormitory Authority of the State of New York.
The term bonds are due 2035 and 2036. The 2035 bonds have a 4.5% coupon and a 4.655% yield, and the 2036 bonds have a 5% coupon and a 4.68% yield.
Goldman, Sachs & Co. was the lead manager for the negotiated sale. The co-managers are Citigroup Global Markets, UBS Investment Bank, JPMorgan, Lehman Brothers, Loop Capital Markets, Merrill Lynch, Morgan Stanley, M.R. Beal & Co. and Sterne, Agee & Leach Co.
The center plans to use the proceeds to redeem a portion of its series 2002A revenue bonds.
| Issuer: | Memorial Sloan-Kettering Cancer Center
|
| Issue: | Series 2008A-1 revenue bonds
|
| Amount: | $161.99 million
|
| Type: | Negotiated
|
| Underwriter: | Goldman, Sachs & Co. (lead); Citigroup Global Markets; UBS Investment Bank; JPMorgan; Lehman Brothers; Loop Capital Markets; Merrill Lynch; Morgan Stanley; M.R. Beal & Co.; Sterne, Agee & Leach
|
| Ratings: | Moody's: Aa2
|
| S&P: AA
|
| Fitch: AA
|
| Pricing date: | April 15
|
|
|
| Maturity | Type | Coupon | Yield
|
| 2035 | Term | 4.5% | 4.655%
|
| 2036 | Term | 5% | 4.680%
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
